ࡱ> PRO#` bjbj5G5G DW-W- 4$|<$n!HPPPPP  $"h%!!PP(! PP  BPD p9 <>!0n!0&0&&0&!!n!$$$D h$$$$h$$$  MDSU 0-3 4-11 12-23 2-3 4-5 6-8 9-10 11 12+ Age Amox/Aug: max 30/mg/kg/day if < 3 mo months------------- years---------------------------------------------------------------------------- nl dose: 25-40-50 mg/kg/d 6-11 12-17 18-23 24-35 36-47 48-59 60-71 72-95 >96 lbs. hi-dose: 80-90mg/kg/day bid 3-5 6-8 8-10 11-16 16-21 22-27 27-32 32-43 >43 kg.  40 80 120 160 240 320 400 480 650 1 1 2 -- -- -- -- -- -- 2.5 4 5 7.5 10 12.5 15 20 1 1 2 3 4 5 6 8 -- 1 1 2 2 3 4 6 -- -- -- -- 1 -- 1 2 -- -- -- -- 2.5 -- -- 5 -- -- -- -- 2.5 5 7.5 -- 10 15  -- 1.25 2.5 3.75 5 6.25 7.5 10 20 -- 2.5 5 7.5 10 12.5 15 20 20  (0.25) (1) 2.5 -- (5) -- (7.5) (10) -- -- -- -- (1.25) -- 2.5 -- 3.75 5 -- MDSU by wt. 2.5 -- 5 7.5 -- -- 10  MDSU 2.5 4 5 7.5 10 -- 15 20=1DS tab  2 4 5 7 10 12.5 15 -- -- -- -- 2mg 2mg 4mg 4mg 4mg -- --Tylenol (Q4 prn) mg Drops (80mg/0.8mL dropper): 15mL btls Elixir (160mg/5mL): 60/120mL bottles (mL) Chewable tablets (80 mg.): btls of 30 Ped Supp 120 mg Adult Tabs 325 mg Extra-str adult liq (500mg/5mL): 240mL btl (mL) Tyl. 120 mg/Codeine 12 mg Elixir: 5mL (mL) ibuprofen elixir (100mg/5mL): 5 mg/kg: T<102.5 (mL; double for first day) 10 mg/kg:T>102.5 (mL; double for first day) Zithromax 100/5mL (15mL bottle) (mL) 200/5mL (15/22.5/30 mL bottles) (mL) Pediazole (Q6) 200 erythro-600 sulfa/5mL; sulfa: 150 mg/kg/day 100+200mL btls (mL) Bactrim Susp. 40TMP+200SMX/5mL (mL) Amoxicillin (High) 400mg/5mL;85 mg/kg/day (mL) Zofran (4mg/5mL, 4mg tab) common pediatric ED drug reference card -- Keith Conover, M.D., FACEP, Mercy Hospital of Pittsburgh v2.1 4/25/2007 Medication Bolus Starting Drip (70 kg adult) Cardizem 10-20 mg 5-15 mg/hr Dobutamine NA 2-15 mcg/kg/min (up to 40) (500mg/250 ml) Dopamine NA 5-20 g/kg/min (800mg/500mL@13-53mL/hr) Epinephrine NA 2-10 g/min (1mg/250@30-150mL/hr) Integrilin 12.6 mg (180 mcg/kg, max 22.6 mg)/1-2 min; 2 mcg/kg/min (max: 15 mg/hour) Labetalol 10-20 mg/2 Q 10 0.5-2 mg/min (60 mg/hr) Nicardipine 0.5 mg Q15' 0-15 mg/hr (0-15 mg/hr) Nipride NA 0.5-2 mcg/kg/min (4.2 mg/hr) NTG 50 mcg-2mg Q3 10-50 mcg/min (0.1-0.25 mcg/kg/min) Procainamide NA 2.5g/250mL@180mL/hr to total 120mL (30mg/min to total 17 mg/kg (1.2g)) Propofol 20-50mg 0.1-0.2 mg/kg/min (420 mg/hr) Pitt ICU Potassium replacement protocol (goal K+ > 3.5 mEq/l) 1. Enteral route available: * If K+ < 2.5 , give KCl 20 mEq PO and KCl 20 mEq IV. Check K+ level in 6 hrs. * If K+ 2.5-3.0, give KCl 20 mEq PO and KCl 10 mEq IV. Check K+ level in 6 hrs. * If K+ >3.1 , give KCl 20 mEq PO. Check K+ level in 6 hours. 2. Enteral route Not Available: * If K+ < 2.5, give KCl 40 mEq IV. Check K+ level 60 minutes after last KCl. * If K+ 2.5-3.0, give KCl 30 mEq IV. Check K+ level 60 minutes after last KCl. * If K+ 3.1-3.5, give KCl 20 mEq IV. Check K+ level 60 minutes after last KCl. Pitt ICU Phosphorus replacement protocol * Phosphate replaced with potassium phosphate (KPO4) unless K+> 4.0 mEq/L * subtract K phos from total K ordered (15 mmole KPO4 = 22 mEq K+) * Replace phosphate with sodium phosphate if K+ is > 4.0 mEq/L. Phosphate (mg/dl) Dose (IV) mmol Rate Recheck Level 1.0-2.0 15 Over 4 hrs In AM < 1.0 30 Over 6 hrs 4 hours 1 microgram=0.001 milligram 1000 mcg=1 mg /0367ADER[ôrcWH/h_ThpCJ OJQJaJ $h_ThsJCJ OJQJaJ mHsH-h_ThuZB*CJ OJQJaJ mHphsH0h_ThsJ5B*CJ OJQJaJ mHphsH'h_ThuZ5CJ OJQJaJ mHsH-h_Th4f56CJ OJQJ]aJ mHsH-h_Thy56CJ OJQJ]aJ mHsH-h_ThuZ56CJ OJQJ]aJ mHsH$h_ThuZCJ OJQJaJ mHsH$h_ThyCJ OJQJaJ mHsH     2 3 4 6 8 A B E F ^ ` b ŶmXEX6h_ThyCJ OJQJaJ %h_ThuZB*CJ OJQJaJ ph(h_ThuZ5B*CJ OJQJaJ ph%h_Thy56CJ OJQJ]aJ %h_ThuZ56CJ OJQJ]aJ h_ThuZ5CJ OJQJaJ $h_ThpCJ OJQJaJ mHsHh_ThuZCJ OJQJaJ (h_ThuZ56CJ OJQJ\]aJ (h_Thy56CJ OJQJ\]aJ h_Thp5CJ OJQJaJ b c j w x  崡||gTgDh_Thi 5CJ OJQJaJ %h_Thi B*CJ OJQJaJ ph(h_Thi 5B*CJ OJQJaJ phh_ThuZ5CJ OJQJaJ (h_ThuZ5B*CJ OJQJaJ ph%h_Thy56CJ OJQJ]aJ %h_ThuZ56CJ OJQJ]aJ h_ThyCJ OJQJaJ h_Th,CJ OJQJaJ h_ThuZCJ OJQJaJ h,CJ OJQJaJ  aopqy­whVDV5hr\5>*CJ OJQJaJ "h_Th6*f5>*CJ OJQJaJ "h_Th~V5>*CJ OJQJaJ h_Th~VCJ OJQJaJ h_CJ OJQJaJ h_ThuZCJ OJQJaJ hr\CJ OJQJaJ hVhVCJ OJQJaJ (hVhV5B*CJ OJQJaJ phhVCJ OJQJaJ hi 56CJ OJQJ]aJ %h_Thi 56CJ OJQJ]aJ h_Thi CJ OJQJaJ  plH$ & P P:rPjLd^j`LgdeD! & P PP pd^ `pIkd $$Ift 0" aytsH_' # 8Tp @ dt$If^ `gdr\ůsYI9I&Y&$h_Th)gCJ OJQJaJ mHsHheDCJ OJQJaJ mHsHhbCJ OJQJaJ mHsH3h_Th)g56B*CJ OJQJaJ mHphsH0hr\hr\5B*CJ OJQJaJ mHphsHhr\CJ OJQJaJ mHsH$hr\hr\CJ OJQJaJ mHsH*hr\5B*CJ OJQJaJ mHphsH-hr\56B*CJ OJQJaJ mHphsH"h_Th~V5>*CJ OJQJaJ "h_Th5>*CJ OJQJaJ .aGbc" # P PPuEdt^u`Egdr\" # P PPjLdt^j`Lgdr\$ & P P:rPjLdt^j`Lgdr\!').9;=?Z\akmn$%&Gͺͺ͠ͺ͠{͠h͠h͠$h_ThWCJ OJQJaJ mHsH!heD6CJ OJQJaJ mHsH'h_Th)g6CJ OJQJaJ mHsH3h_Th)g56B*CJ OJQJaJ mHphsH$h_ThyCJ OJQJaJ mHsH$h_Th)gCJ OJQJaJ mHsHheDCJ OJQJaJ mHsHhbCJ OJQJaJ mHsH"GJKL ŲŅrrrŅ_L_$h_Thq&OCJ OJQJaJ mHsH$h_ThdX*CJ OJQJaJ mHsH$h_ThyCJ OJQJaJ mHsH$h_Th)gCJ OJQJaJ mHsH3h_Th)g56B*CJ OJQJaJ mHphsH$h_Th)|CJ OJQJaJ mHsHheDCJ OJQJaJ mHsHhbCJ OJQJaJ mHsH3h_Th)|56B*CJ OJQJaJ mHphsHEFab>CbMNSVWanvwxyҿҿ|iVi۷A7XNl`2V|j5{?o65kt/f >@A5]m`G/m{736f{w;6f#,:΢,:΢,:΢,:΢,:΢,:΢,:΢,:΢,:΢,:YtYc?{}U_=}|~>BͨA70 X}7]m`n6`շz٠Ǡշހ9] n%umg}|zm/:aYd}\:̟; ?8?W;NSMFsA8<{: tV CgtV@Y)ЧYAg@JJgu:+VYQ:+ǬYΊY9fΊtV|1tVtVYbΚB{atP,#VARv?H䵇.t W@:^%|0n 8z ?JυYAgG r :+>JgVSYQ:+謜pz~ @݈(^Uh7<a` dVwM'>β'Y)5߉ ut_0{̵ N*T4h%bIAye*t4=ZmmvlUNuiJ,Z嬇:U}FuZLŗ=f,H<$C'stpt@e[] BPvVIgvz׽_m$jY#V[St]w7:jwYm֭B UX_gٓsugD z$DgzY5v E3yߑ{MZg;m-mÐD :,2uV+`GU78M5kJV-Yʲ)5 Dg@g,{O/S;k=}E䶲F{>s9![D<-:ˀ8Ϊ+:+g͗gz[9cNYaP;ǝyΪY:2VYc! g%t&РPzIz%:/] YE B2 RЀ25IEc*:PHYMAugcf'.GڒRACtv5ye'tJJS9kJUsP5;* Q`u-WW!JYR8fߚρZm)Z39$squmi7:ê;} 6U -^YaUJUonru"garT;d4hCU@9.`*G~9w',;gACAeh<5: ` ; 7sщ9K0ULwH,7`~*U9t(q|^&գN 8W;}jg٩@Gw:k"{nDr7jDg9$Yjw -{ݲRuLv{GT-GUY-:'Y)oZ۝:+gM |dzdp#R;/:n28LQg} *85Ne g髻 znhFgF r :+>JgVSYQ:+謜"Yuv! @sc.8zxgh1)oFǃ?at ug G.x`0N8#?IENDB`h$$If!vh55 #v#v :V t 55 4aytsH_L@L 0Normal1$CJOJQJ_HhmH sH tH DA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k@(No List LOL CX1+ & ` `  `O CX2_ J `0p ` 0p `0p p^ `p               D 4D hD\=qs0NPs/2MNo Kw8p.aG b  c N w  D |      00000@00x0x0x0x0x0x0x0x0x0x0x0x0x0x0x0x0x0x0x0x0x0x0x 0x0x0x0x0x0x0x0x0x0x0x0x0x0x0x0x0x0x0x0x0x 0| @000000000@000000@0@0@0@0@0@0@0@00@00000000000000000000000 00AN P . b G !    l,"$WfFTJм4HD @$(  bB  c $D"TB  c $DTB  c $DTB  c $DTB  c $DTB  c $DTB  c $DB S  ?qN/2 P PtP Vt"DDtNNt0LTt.Qat,t7;Y[{~!$+.BEKknqsuw2ae!")*9;=?\]kn$&JLrs    E F a d   > C b e  M N V W a b v y   d e l n  ]c!(=pKvw7o-.`aFG~  a b  b c M N v w   C D { |  33333qqPs0023Lnoao  ae  $weaW43eDyuZ/!ZP&b'dX*1O58%:@V7 ՜.+,0 hp  none  ───────────────────────────────────────────────────────────────────────────── Title  !"$%&'()*,-./0123456789:;<=>@ABCDEFHIJKLMNQRoot Entry FPISData #1Table+0&WordDocumentDSummaryInformation(?DocumentSummaryInformation8GCompObjq  FMicrosoft Office Word Document MSWordDocWord.Document.89q